Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KW-3902IV with IV Furosemide in CHF and Renal Impairment
NCT00159614Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) and Renal Insufficiency (RI) comparing KW-3902IV + Furosemide with Placebo + Furosemide (2 arms). Primary endpoint: Renal Function. Started Sep 2005; status: completed.
02
Drugs
rolofylline
03
Conditions
heart failure (HF)Renal Insufficiency (RI)
Beyond the preview
Go deeper on NCT00159614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159614.